LiCoO


Journal

Particle and fibre toxicology
ISSN: 1743-8977
Titre abrégé: Part Fibre Toxicol
Pays: England
ID NLM: 101236354

Informations de publication

Date de publication:
29 01 2020
Historique:
received: 06 08 2019
accepted: 15 01 2020
entrez: 31 1 2020
pubmed: 31 1 2020
medline: 15 12 2020
Statut: epublish

Résumé

Li-ion batteries (LIB) are used in most portable electronics. Among a wide variety of materials, LiCoO We assessed the mutagenic potential of LCO and LTO particles in vitro by performing a cytokinesis-block micronucleus (MN) assay with rat lung epithelial cells (RLE), as well as in vivo in alveolar type II epithelial (AT-II) cells. LCO particles induced MN in vitro at non-cytotoxic concentrations and in vivo at non-inflammatory doses, indicating a primary genotoxic mechanism. LTO particles did not induce MN. Electron paramagnetic resonance and terephthalate assays showed that LCO particles produce hydroxyl radicals (•OH). Catalase inhibits this •OH production. In an alkaline comet assay with the oxidative DNA damage repair enzyme human 8-oxoguanine DNA glycosylase 1, LCO particles induced DNA strand breaks and oxidative lesions. The addition of catalase reduced the frequency of MN induced by LCO particles in vitro. We report the mutagenic activity of LCO particles used in LIB in vitro and in vivo. Our data support the role of Co(II) ions released from these particles in their primary genotoxic activity which includes the formation of •OH by a Fenton-like reaction, oxidative DNA lesions and strand breaks, thus leading to chromosomal breaks and the formation of MN. Documenting the genotoxic potential of the other LIB particles, especially those containing Co and/or Ni, is therefore needed to guarantee a safe and sustainable development of LIB.

Sections du résumé

BACKGROUND
Li-ion batteries (LIB) are used in most portable electronics. Among a wide variety of materials, LiCoO
RESULTS
We assessed the mutagenic potential of LCO and LTO particles in vitro by performing a cytokinesis-block micronucleus (MN) assay with rat lung epithelial cells (RLE), as well as in vivo in alveolar type II epithelial (AT-II) cells. LCO particles induced MN in vitro at non-cytotoxic concentrations and in vivo at non-inflammatory doses, indicating a primary genotoxic mechanism. LTO particles did not induce MN. Electron paramagnetic resonance and terephthalate assays showed that LCO particles produce hydroxyl radicals (•OH). Catalase inhibits this •OH production. In an alkaline comet assay with the oxidative DNA damage repair enzyme human 8-oxoguanine DNA glycosylase 1, LCO particles induced DNA strand breaks and oxidative lesions. The addition of catalase reduced the frequency of MN induced by LCO particles in vitro.
CONCLUSIONS
We report the mutagenic activity of LCO particles used in LIB in vitro and in vivo. Our data support the role of Co(II) ions released from these particles in their primary genotoxic activity which includes the formation of •OH by a Fenton-like reaction, oxidative DNA lesions and strand breaks, thus leading to chromosomal breaks and the formation of MN. Documenting the genotoxic potential of the other LIB particles, especially those containing Co and/or Ni, is therefore needed to guarantee a safe and sustainable development of LIB.

Identifiants

pubmed: 31996255
doi: 10.1186/s12989-020-0338-9
pii: 10.1186/s12989-020-0338-9
pmc: PMC6990559
doi:

Substances chimiques

Oxides 0
Particulate Matter 0
lithium cobalt oxide 0
Hydroxyl Radical 3352-57-6
Cobalt 3G0H8C9362

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

6

Références

Toxicology. 2011 May 10;283(2-3):65-87
pubmed: 21414382
Chem Res Toxicol. 1995 Jun;8(4):600-6
pubmed: 7548741
Carcinogenesis. 2003 Nov;24(11):1793-800
pubmed: 12949052
Inhal Toxicol. 2002 Jan;14(1):57-78
pubmed: 12122560
IARC Monogr Eval Carcinog Risks Hum. 2006;86:1-294
pubmed: 16906675
Astrobiology. 2015 May;15(5):371-80
pubmed: 25946080
Environ Health Perspect. 2016 Jun;124(6):713-21
pubmed: 26600562
Am J Physiol. 1991 Aug;261(2 Pt 1):L84-91
pubmed: 1872419
Mutagenesis. 1992 Nov;7(6):407-10
pubmed: 1474915
Mol Biotechnol. 2004 Mar;26(3):249-61
pubmed: 15004294
Crit Rev Toxicol. 2018 Aug;48(7):522-539
pubmed: 30203727
Sci Rep. 2012;2:481
pubmed: 22745900
Part Fibre Toxicol. 2014 Mar 27;11:14
pubmed: 24669904
Carcinogenesis. 2007 Mar;28(3):625-31
pubmed: 16973674
Arch Toxicol. 2018 May;92(5):1673-1684
pubmed: 29550861
Carcinogenesis. 1998 Nov;19(11):2021-9
pubmed: 9855019
Part Fibre Toxicol. 2019 Sep 18;16(1):35
pubmed: 31533843
Nature. 2001 Nov 15;414(6861):359-67
pubmed: 11713543
Mutat Res. 2003 Oct 7;540(2):153-63
pubmed: 14550499
Mutat Res. 2000 Nov 20;455(1-2):81-95
pubmed: 11113469
Int Rev Exp Pathol. 1980;22:131-91
pubmed: 7005143
Part Fibre Toxicol. 2014 Dec 14;11:67
pubmed: 25497478
Mutagenesis. 2017 Jan;32(1):233-241
pubmed: 27815329
J Natl Cancer Inst. 2013 Sep 4;105(17):1270-83
pubmed: 23940289
J Phys Chem Lett. 2015 Apr 16;6(8):1357-62
pubmed: 26263135
Nano Lett. 2015 Aug 12;15(8):5168-77
pubmed: 26176939
Toxicol Sci. 2002 Jun;67(2):275-83
pubmed: 12011487
Mutat Res. 2016 Oct - Dec;770(Pt A):106-118
pubmed: 27894680
Mutat Res. 2003 Dec 10;533(1-2):67-97
pubmed: 14643413
In Vitro Cell Dev Biol Anim. 1995 Jul-Aug;31(7):516-27
pubmed: 8528500
Int J Cancer. 2004 May 10;109(6):799-809
pubmed: 15027112
ACS Appl Mater Interfaces. 2017 Jun 14;9(23):19870-19880
pubmed: 28534410
Part Fibre Toxicol. 2018 May 21;15(1):23
pubmed: 29783987

Auteurs

Violaine Sironval (V)

Louvain centre for Toxicology and Applied Pharmacology, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Avenue Hippocrate 57, box B1.57.06, 1200, Brussels, Belgium. violaine.sironval@uclouvain.be.

Vittoria Scagliarini (V)

Louvain centre for Toxicology and Applied Pharmacology, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Avenue Hippocrate 57, box B1.57.06, 1200, Brussels, Belgium.

Sivakumar Murugadoss (S)

Laboratory of Toxicology, Unit of Environment and Health, Department of Public Health and Primary Care, Katholieke Universiteit Leuven, Herestraat 49 - O&N1 - Room: 07.702, box 706, 3000, Leuven, Belgium.

Maura Tomatis (M)

Department of Chemistry and "G. Scansetti" Interdepartmental Center for Studies on Asbestos and Other Toxic Particulates, University of Torino, Via P. Giuria 7, 10125, Torino, Italy.

Yousof Yakoub (Y)

Louvain centre for Toxicology and Applied Pharmacology, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Avenue Hippocrate 57, box B1.57.06, 1200, Brussels, Belgium.

Francesco Turci (F)

Department of Chemistry and "G. Scansetti" Interdepartmental Center for Studies on Asbestos and Other Toxic Particulates, University of Torino, Via P. Giuria 7, 10125, Torino, Italy.

Peter Hoet (P)

Laboratory of Toxicology, Unit of Environment and Health, Department of Public Health and Primary Care, Katholieke Universiteit Leuven, Herestraat 49 - O&N1 - Room: 07.702, box 706, 3000, Leuven, Belgium.

Dominique Lison (D)

Louvain centre for Toxicology and Applied Pharmacology, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Avenue Hippocrate 57, box B1.57.06, 1200, Brussels, Belgium.

Sybille van den Brule (S)

Louvain centre for Toxicology and Applied Pharmacology, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Avenue Hippocrate 57, box B1.57.06, 1200, Brussels, Belgium.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH